Related Experiment Video
Updated: Feb 25, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.7K
SMRI Biomarkers Predict Electroconvulsive Treatment Outcomes: Accuracy with Independent Data Sets
Rongtao Jiang1,2, Christopher C Abbott3, Tianzi Jiang1,2,4
1Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Summary
Electroconvulsive therapy (ECT) can predict treatment response in major depressive disorder (MDD) patients using pre-treatment gray matter (GM) brain scans. This study identifies specific brain regions that predict ECT effectiveness, aiding in personalized depression treatment.
Area of Science:
- Neuroimaging
- Psychiatry
- Computational Neuroscience
Background:
- Electroconvulsive therapy (ECT) is a rapid and effective treatment for major depressive disorders (MDDs).
- Identifying predictors of ECT response is crucial for personalized treatment strategies in MDD.
- Brain imaging markers, specifically gray matter (GM) density, show promise in predicting antidepressant treatment outcomes.
Purpose of the Study:
- To predict post-ECT changes in depressive ratings and remission status using pre-ECT GM in MDD patients.
- To validate identified GM predictors of ECT response across multiple independent datasets.
- To investigate the relationship between treatment-predictive and treatment-responsive brain regions in the context of ECT.
Main Methods:
- Utilized pre-ECT GM data from 38 MDD patients to predict treatment response.
- Validated predictive models using two independent, age-matched datasets.
- Analyzed changes in GM density post-ECT in MDD patients.
Main Results:
- Six GM regions (right hippocampus/parahippocampus, right orbitofrontal gyrus, right inferior temporal gyrus, left postcentral gyrus/precuneus, left supplementary motor area, left lingual gyrus) predicted ECT response.
- Achieved high accuracy (89-90%) in predicting remission across three independent datasets.
- Observed GM density increases post-ECT in the left supplementary motor cortex and left postcentral gyrus/precuneus.
Conclusions:
- Pre-ECT GM can accurately predict ECT response and remission in MDD patients.
- Treatment-predictive and treatment-responsive brain regions may differ anatomically but are functionally linked.
- This multi-site study provides validated biomarkers for ECT, potentially enabling more effective interventions for electroconvulsive treatment.
